234 related articles for article (PubMed ID: 12110684)
21. G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects.
Bompadre SG; Sohma Y; Li M; Hwang TC
J Gen Physiol; 2007 Apr; 129(4):285-98. PubMed ID: 17353351
[TBL] [Abstract][Full Text] [Related]
22. Restoration of NBD1 thermal stability is necessary and sufficient to correct ∆F508 CFTR folding and assembly.
He L; Aleksandrov AA; An J; Cui L; Yang Z; Brouillette CG; Riordan JR
J Mol Biol; 2015 Jan; 427(1):106-20. PubMed ID: 25083918
[TBL] [Abstract][Full Text] [Related]
23. Revertant mutants modify, but do not rescue, the gating defect of the cystic fibrosis mutant G551D-CFTR.
Xu Z; Pissarra LS; Farinha CM; Liu J; Cai Z; Thibodeau PH; Amaral MD; Sheppard DN
J Physiol; 2014 May; 592(9):1931-47. PubMed ID: 24591578
[TBL] [Abstract][Full Text] [Related]
24. Binding site of activators of the cystic fibrosis transmembrane conductance regulator in the nucleotide binding domains.
Moran O; Galietta LJ; Zegarra-Moran O
Cell Mol Life Sci; 2005 Feb; 62(4):446-60. PubMed ID: 15719171
[TBL] [Abstract][Full Text] [Related]
25. A conserved region of the R domain of cystic fibrosis transmembrane conductance regulator is important in processing and function.
Pasyk EA; Morin XK; Zeman P; Garami E; Galley K; Huan LJ; Wang Y; Bear CE
J Biol Chem; 1998 Nov; 273(48):31759-64. PubMed ID: 9822639
[TBL] [Abstract][Full Text] [Related]
26. Nucleotide-binding domain 1 of cystic fibrosis transmembrane conductance regulator production of a suitable protein for structural studies.
Duffieux F; Annereau JP; Boucher J; Miclet E; Pamlard O; Schneider M; Stoven V; Lallemand JY
Eur J Biochem; 2000 Sep; 267(17):5306-12. PubMed ID: 10951189
[TBL] [Abstract][Full Text] [Related]
27. Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure.
Lewis HA; Zhao X; Wang C; Sauder JM; Rooney I; Noland BW; Lorimer D; Kearins MC; Conners K; Condon B; Maloney PC; Guggino WB; Hunt JF; Emtage S
J Biol Chem; 2005 Jan; 280(2):1346-53. PubMed ID: 15528182
[TBL] [Abstract][Full Text] [Related]
28. Expression and intracellular processing of chimeric and mutant CFTR molecules.
Pollet JF; Van Geffel J; Van Stevens E; Van Geffel R; Beauwens R; Bollen A; Jacobs P
Biochim Biophys Acta; 2000 Jan; 1500(1):59-69. PubMed ID: 10564718
[TBL] [Abstract][Full Text] [Related]
29. The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis.
Thibodeau PH; Richardson JM; Wang W; Millen L; Watson J; Mendoza JL; Du K; Fischman S; Senderowitz H; Lukacs GL; Kirk K; Thomas PJ
J Biol Chem; 2010 Nov; 285(46):35825-35. PubMed ID: 20667826
[TBL] [Abstract][Full Text] [Related]
30. Building an understanding of cystic fibrosis on the foundation of ABC transporter structures.
Mendoza JL; Thomas PJ
J Bioenerg Biomembr; 2007 Dec; 39(5-6):499-505. PubMed ID: 18080175
[TBL] [Abstract][Full Text] [Related]
31. Modulation of protein kinase CK2 activity by fragments of CFTR encompassing F508 may reflect functional links with cystic fibrosis pathogenesis.
Pagano MA; Arrigoni G; Marin O; Sarno S; Meggio F; Treharne KJ; Mehta A; Pinna LA
Biochemistry; 2008 Jul; 47(30):7925-36. PubMed ID: 18597485
[TBL] [Abstract][Full Text] [Related]
32. Deletion of Phenylalanine 508 in the First Nucleotide-binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator Increases Conformational Exchange and Inhibits Dimerization.
Chong PA; Farber PJ; Vernon RM; Hudson RP; Mittermaier AK; Forman-Kay JD
J Biol Chem; 2015 Sep; 290(38):22862-78. PubMed ID: 26149808
[TBL] [Abstract][Full Text] [Related]
33. A defective flexible loop contributes to the processing and gating defects of the predominant cystic fibrosis-causing mutation.
Chen X; Zhu S; Zhenin M; Xu W; Bose SJ; Wong MP; Leung GPH; Senderowitz H; Chen JH
FASEB J; 2019 Apr; 33(4):5126-5142. PubMed ID: 30668920
[TBL] [Abstract][Full Text] [Related]
34. Mutation of the aromatic amino acid interacting with adenine moiety of ATP to a polar residue alters the properties of multidrug resistance protein 1.
Zhao Q; Chang XB
J Biol Chem; 2004 Nov; 279(47):48505-12. PubMed ID: 15355964
[TBL] [Abstract][Full Text] [Related]
35. Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator.
Lewis HA; Buchanan SG; Burley SK; Conners K; Dickey M; Dorwart M; Fowler R; Gao X; Guggino WB; Hendrickson WA; Hunt JF; Kearins MC; Lorimer D; Maloney PC; Post KW; Rajashankar KR; Rutter ME; Sauder JM; Shriver S; Thibodeau PH; Thomas PJ; Zhang M; Zhao X; Emtage S
EMBO J; 2004 Jan; 23(2):282-93. PubMed ID: 14685259
[TBL] [Abstract][Full Text] [Related]
36. Organic solutes rescue the functional defect in delta F508 cystic fibrosis transmembrane conductance regulator.
Zhang XM; Wang XT; Yue H; Leung SW; Thibodeau PH; Thomas PJ; Guggino SE
J Biol Chem; 2003 Dec; 278(51):51232-42. PubMed ID: 14532265
[TBL] [Abstract][Full Text] [Related]
37. Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels.
Mickle JE; Milewski MI; Macek M; Cutting GR
Am J Hum Genet; 2000 May; 66(5):1485-95. PubMed ID: 10762539
[TBL] [Abstract][Full Text] [Related]
38. Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2.
Gregory RJ; Rich DP; Cheng SH; Souza DW; Paul S; Manavalan P; Anderson MP; Welsh MJ; Smith AE
Mol Cell Biol; 1991 Aug; 11(8):3886-93. PubMed ID: 1712898
[TBL] [Abstract][Full Text] [Related]
39. The short apical membrane half-life of rescued {Delta}F508-cystic fibrosis transmembrane conductance regulator (CFTR) results from accelerated endocytosis of {Delta}F508-CFTR in polarized human airway epithelial cells.
Swiatecka-Urban A; Brown A; Moreau-Marquis S; Renuka J; Coutermarsh B; Barnaby R; Karlson KH; Flotte TR; Fukuda M; Langford GM; Stanton BA
J Biol Chem; 2005 Nov; 280(44):36762-72. PubMed ID: 16131493
[TBL] [Abstract][Full Text] [Related]
40. Optimization of the degenerated interfacial ATP binding site improves the function of disease-related mutant cystic fibrosis transmembrane conductance regulator (CFTR) channels.
Tsai MF; Jih KY; Shimizu H; Li M; Hwang TC
J Biol Chem; 2010 Nov; 285(48):37663-71. PubMed ID: 20861014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
